Industry news

• 2019’s medtech industry to weigh hype and realism in equal parts

  25 December 2018 Conor Hale / FierceBiotech

  Heading into 2019, the medtech industry is, in some ways, the strongest it’s ever been—though its players may see new challenges in trying to balance hype and scientific promise against cold reality and economics.

• Personalized medicine will have the biggest impact on pharma industry in 2019

  24 December 2018 GMP News

  According to the annual outlook report, ‘The State of the Biopharmaceutical Industry   – 2019’, 31% of global industry respondents believe that immuno-oncology will have the greatest impact on the pharmaceutical sector in 2019 among a range of industry trends.

• Researchers conducted first trial of personalized vaccine for brain cancer

  24 December 2018 GMP News

  Clinical study demonstrates proof-of-concept of the Glioma Actively Personalized Vaccine Consortium (GAPVAC) approach in a pioneering multi-center, multi-national study co-funded by the European Union.

• EMA released its draft of ‘Regulatory Science to 2025’

  21 December 2018 GMP News

  European Medicines Agency (EMA) has published its draft of ‘Regulatory Science to 2025’ strategy for a six-month public consultation. This is a proposed plan for advancing the Agency’s engagement with regulatory science over the next five to ten years, covering both human and veterinary medicines.

• Digital therapeutics from apps to smart inhalers, brought to you by pharma

  21 December 2018 Beth Snyder Bulik / FiercePharma

  While pharma-to-patient technologies have been around for several years, they’ve been largely experimental—and frankly, hit or miss. But as patients continue to take a more active role in their healthcare and wellness, the industry's interest in technology assistance—sometimes actual virtual assistants like Apple's Siri or Amazon’s Alexa—is booming.

• Politics and tech cap 2018 in pharma marketing, and they'll trend in 2019, too

  20 December 2018 Beth Snyder Bulik / FiercePharma

  Digital therapeutics, advocacy group tumult, even more cancer ads and innovation challenges and of course, politics. Those were some of the biggest themes for pharma marketing in 2018, but they're also the trends that will continue into next year.

• Embracing the future of work to unlock R&D productivity

  20 December 2018 Deloitte

  The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. However, there are opportunities to reverse this trend, which will require new ways of working and a complete digital transformation to unlock R&D productivity and deliver the next generation of scientific breakthroughs.

• Finnish-Russian Commission for Economic Cooperation Meeting

  19 December 2018 GMP News

  A meeting of the working group on standardization and compliance issues of the Finnish-Russian Intergovernmental Commission for Economic Cooperation was held in the Ministry of Industry and Trade of the Russian Federation.

• Warning, investors: Way too many drugs will be vying for market share in 15 diseases

  19 December 2018 Arlene Weintraub / FiercePharma

  Biopharma knows this industry plague all too well: One company finds a new way to tackle a disease and a whole bunch of rivals pile in. And that overcrowding raises the risks for all players—and raises doubts about the optimistic valuations investors are placing on these companies.

• Brexit May Cause Exodus of Life Sciences Professionals from UK, Notes Research

  18 December 2018 BioPharm International

  According to research from Kelly Services (a staffing firm), 14% of life science professionals based in the United Kingdom may move abroad if Brexit results in negative changes to economic conditions.